These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1081730)

  • 1. Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients.
    Munthe E; Hoyeraal HM; Froland SS; Mellbye OJ; Kåss E; Natvig JB
    Rheumatology; 1975; 6():43-51. PubMed ID: 1081730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The complement system].
    Lambert PH
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The C'-3 constituent of the complement and rheumatoid factors in serum-synovial fluid paris in progressive polyarthritis and reactive synovites due to local causes (author's transl)].
    Hrncír Z; Tichý M; Salavec M; Vavrina J
    Cas Lek Cesk; 1976 Dec; 115(48):1487-90. PubMed ID: 1000565
    [No Abstract]   [Full Text] [Related]  

  • 9. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Ruddy S; Fearon DT; Austen KF
    Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid synovitis: complement and immune complexes.
    Schur PH; Britton MC; Franco AE; Corson JM; Sosman JL; Ruddy S
    Rheumatology; 1975; 6():34-42. PubMed ID: 1202605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
    Perrin LH; Shiraishi S; Stroud RM; Lambert PH
    J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
    Emmrich J; Geiler G
    Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C4 component of complement, rheumatoid factors and circulating immunocomplexes in rheumatoid-arthritis and reactive synovitides of local origin; serum synovial fluid].
    Hrncír Z; Tichý M; Salavec M; Vavrina J
    Cas Lek Cesk; 1978 Dec; 117(49):1526-9. PubMed ID: 737699
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.
    Svartman M; Potter EV; Poon-King T; Earle DP
    J Clin Invest; 1975 Jul; 56(1):111-7. PubMed ID: 1141429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immune parameters of synovial fluid and blood in rheumatoid arthritis.
    Dorwart BB; Hebert J; Schumacher HR; Abdou NI
    J Rheumatol; 1975 Dec; 2(4):363-72. PubMed ID: 1082030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.